Speaker: Cynthia Yee & Amrinder Singh, Vensana Capital
Thursday, April 28, 1:00 to 2:00 PM PT
A foundational element to building a successful company is strong leadership, which goes beyond a company’s management team to include its board of directors. The primary role of a company’s board of directors is to provide corporate oversight and governance for management and to represent shareholders’ interests. However, an effective board can also contribute to a company’s vision and strategy and ensure alignment on the vision for the business.
This session will discuss key considerations for entrepreneurs when building a board of directors as well as best practices for aligning incentives and engaging both independent and investor directors to maximize value for all shareholders.
The 2022 Rosenman InnovatorDEMO DAY is fast approaching! Join us Wednesday, June 8th for a private showcase event.
The UCSF Rosenman Institute will select 10 promising early-stage health technology and device companies. These companies have been heavily pre-screened and advised by our cross-functional expert network, and will be receiving in-kind services from our partners. The Innovators are seeking seed-stage to Series A funding. Each will give a 3-minute pitch. Pitch presentations and networking will be remote and will take place on the same platform. Link will be provided.
This event is by invitation only. If you’re interested in attending, please fill out this form.
Speaker: Liz Canis, Founder & CEO of The Pivot Group
Tuesday, April 5, 1:00 to 2:00 PM PT
The healthcare marketplace is populated with innovative solutions that improve patient care and the overall experience with the healthcare ecosystem. Payers are increasingly seeking emerging capabilities and companies for investments and partnerships – and a payer can provide a strong avenue to accelerate growth for emerging/early-stage companies. Learn the key components of the payer value creation model to determine whether a payer relationship may benefit your business and how to effectively articulate your solution to garner attention and interest.
Value-based contracts impose risk both on providers and payers. The appropriate structure of a contract is an important component of mitigating your risk as a provider and ensuring that you are paid correctly for the value that you create for a payer. Similarly, a payer wants to be sure that it pays for value and does not over-compensate the provider. The variability inherent in populations and claims, however, poses a risk for the parties. We will discuss different outcomes evaluation methodologies in value-based care contracts. Additionally, we will review a study of variability in outcomes in an accountable care organization contract that shows a considerable risk of under-or over-payment and discuss methods to mitigate the risk to the parties.
Speaker: Dan Brounstein, Senior Vice President & President, North America, Saluda Medical
Tuesday, March 15, 1:00 to 2:00 PM PT
This event has been rescheduled from its original November date.
Dan Brounstein has built and marketed products that have served thousands of patients throughout his career. In this talk, Dan will draw on over 18 years of experience at six different companies to describe the path of a product from idea to fundraising, through testing and clinical trials, ultimately culminating in sales. All questions answered.
Speaker: James Wall, Associate Professor & Pediatric Surgeon, Stanford University
Thursday, March 10, 1:00 to 2:00 PM PT
Who decides whether your technology is adopted by a hospital or healthcare system? It’s the “value committee,” whose members consider whether your solution delivers value that meets the needs of their patients and system. For an inside view of how this committee operates, join us to hear from James Wall, who chaired the value analysis committee at Lucile Packard Children’s Hospital for 5 years.
Launching a company in the health technology industry requires tremendous expertise in the technology and the marketplace as well as strong funding. However, success with all aspects of company building is dependent upon hiring, developing, and retaining the right team to deliver results. Building the right “people” foundation is a key first step in making sure you can manage your most important investment, in your human capital. Understanding the market for compensation, setting up payroll and an attractive set of benefit offerings, and building your talent acquisition and employee engagement practices, all while ensuring compliance with relevant employment laws and regulations, requires expertise in the world of human resources. This session will provide an overview of the key steps to building a strong “people” foundation when launching a new company from the ground up, as well as the best practices that support you in building an enduring culture and successful enterprise over the long term.
Speaker: James Wieselman Schulman, Global Design Lead, Evernorth Innovation/Cigna
https://www.youtube.com/watch?v=iz9_Nv3ZyZI
Thursday, February 17, 1:00 to 2:00 PM PT
There is nothing greater for a start-up than partnering on a pilot with a large multi-national corporation. Or is there? Giant companies have nothing but money to spend on innovation and a deep bench of talent and resources to draw from. Or do they?
In this talk, James will share insights from his years working with incubators and start-ups around the globe to drive innovation at a Fortune 15 company. He will share how they source and engage with start-ups across business units and will focus on how start-ups can set themselves up for success. He will share several key lessons learned that all start-ups should consider when partnering with large corporations.
He will share both the highs and the lows of his experience working with start-ups and how setting expectations can lead to a great partnership.
Speakers: Ellen Amsel, Medigate, Jean Pawluk, & Yuda Saydun, CyVent
Thursday, November 18, 1:00 to 2:00 PM PT
Cybersecurity is at a turning point. Billions of dollars get invested yearly to protect intellectual property, corporate networks, and state secrets. Yet we see high profile breaches hitting the news almost every day. Healthcare and medical devices are no exception. In fact, they are prime targets for bad actors due to the high value of the IP and the patient information. In this session, our speakers will share their insights on the threat landscape, its impact on the health care industry, and appropriate prevention strategies. The session will provide an overview of the challenges and emerging solutions ahead, along with practical suggestions on how to protect your revenues, operations, and IP while you are growing your company.
Speaker: Edward J. Naughton, Partner, Brown Rudnick
Thursday, October 28, 1:00 to 2:00 PM PT
While increasing technological innovation can aid companies in their HIPAA compliance practices, it can also create entirely new challenges. Join us as Edward Naughton breaks down what early-stage life sciences companies should know about HIPAA, and how they can rise to meet the complications presented by increased utilization of technology in the scientific world.
